Mathematical modeling improves EC50 estimations from classical dose–response curves

The β‐adrenergic response is impaired in failing hearts. When studying β‐adrenergic function in vitro, the half‐maximal effective concentration (EC50) is an important measure of ligand response. We previously measured the in vitro contraction force response of chicken heart tissue to increasing concentrations of adrenaline, and observed a decreasing response at high concentrations. The classical interpretation of such data is to assume a maximal response before the decrease, and to fit a sigmoid curve to the remaining data to determine EC50. Instead, we have applied a mathematical modeling approach to interpret the full dose–response curve in a new way. The developed model predicts a non‐steady‐state caused by a short resting time between increased concentrations of agonist, which affect the dose–response characterization. Therefore, an improved estimate of EC50 may be calculated using steady‐state simulations of the model. The model‐based estimation of EC50 is further refined using additional time‐resolved data to decrease the uncertainty of the prediction. The resulting model‐based EC50 (180–525 nm) is higher than the classically interpreted EC50 (46–191 nm). Mathematical modeling thus makes it possible to re‐interpret previously obtained datasets, and to make accurate estimates of EC50 even when steady‐state measurements are not experimentally feasible.

[1]  David O. Holland,et al.  Graphical Approach to Model Reduction for Nonlinear Biochemical Networks , 2011, PloS one.

[2]  M. Jann,et al.  Drug withdrawal syndromes-- a literature review. , 1980, The Western journal of medicine.

[3]  Gunnar Cedersund,et al.  Mechanistic explanations for counter‐intuitive phosphorylation dynamics of the insulin receptor and insulin receptor substrate‐1 in response to insulin in murine adipocytes , 2012, The FEBS journal.

[4]  C. Rohlicek,et al.  Effects of neonatal hypoxia in the rat on inotropic stimulation of the adult heart. , 2005, Cardiovascular research.

[5]  Thomas C. Rich,et al.  Roles of GRK and PDE4 Activities in the Regulation of β2 Adrenergic Signaling , 2008, The Journal of general physiology.

[6]  Ursula Klingmüller,et al.  Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood , 2009, Bioinform..

[7]  J. Altimiras,et al.  Chronic prenatal hypoxia sensitizes beta-adrenoceptors in the embryonic heart but causes postnatal desensitization. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[8]  Gunnar Cedersund,et al.  Mass and Information Feedbacks through Receptor Endocytosis Govern Insulin Signaling as Revealed Using a Parameter-free Modeling Framework* , 2010, The Journal of Biological Chemistry.

[9]  M. Bruchez,et al.  Detection and Quantification of β2AR Internalization in Living Cells Using FAP-Based Biosensor Technology , 2010, Journal of biomolecular screening.

[10]  Jens Timmer,et al.  Likelihood based observability analysis and confidence intervals for predictions of dynamic models , 2011, BMC Systems Biology.

[11]  J. Altimiras,et al.  CALL FOR PAPERS Fetal and Neonatal Programming: Epigenetic Modification of Phenotype Prenatal hypoxia programs changes in -adrenergic signaling and postnatal cardiac contractile dysfunction , 2013 .

[12]  S. Green,et al.  Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs. , 1992, Molecular pharmacology.

[13]  Edda Klipp,et al.  Systems Biology , 1994 .

[14]  R. Ahlquist,et al.  A study of the adrenotropic receptors. , 1948, The American journal of physiology.

[15]  Martin J. Lohse,et al.  β2-Adrenergic Receptor Redistribution in Heart Failure Changes cAMP Compartmentation , 2010, Science.

[16]  Marisa C Eisenberg,et al.  Determining identifiable parameter combinations using subset profiling. , 2014, Mathematical biosciences.

[17]  Jacob Roll,et al.  Systems biology: model based evaluation and comparison of potential explanations for given biological data , 2009, The FEBS journal.

[18]  H. Steven Wiley,et al.  Receptor downregulation and desensitization enhance the information processing ability of signalling receptors , 2007, BMC Syst. Biol..

[19]  R. Lefkowitz,et al.  PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs/Gi switching. , 2004, Cellular signalling.

[20]  Gunnar Cedersund,et al.  Insulin Signaling in Type 2 Diabetes , 2013, The Journal of Biological Chemistry.

[21]  Lili X. Peng,et al.  Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes , 2006, Proceedings of the National Academy of Sciences.

[22]  Gunnar Cedersund,et al.  A Hierarchical Whole-body Modeling Approach Elucidates the Link between in Vitro Insulin Signaling and in Vivo Glucose Homeostasis* , 2011, The Journal of Biological Chemistry.

[23]  A. McCulloch,et al.  Modeling β-Adrenergic Control of Cardiac Myocyte Contractility in Silico* , 2003, Journal of Biological Chemistry.

[24]  T. K. Harden,et al.  High-affinity binding of agonists to beta-adrenergic receptors on intact cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[26]  J. Spertus,et al.  A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure , 2008, Nature Medicine.

[27]  Henning Schmidt SBaddon: high performance simulation for the Systems Biology Toolbox for MATLAB , 2007, Bioinform..

[28]  V. Bondarenko A Compartmentalized Mathematical Model of the β1-Adrenergic Signaling System in Mouse Ventricular Myocytes , 2014, PloS one.

[29]  B. Kobilka,et al.  Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice. , 2001, Molecular pharmacology.

[30]  Andrew D McCulloch,et al.  Mechanistic systems models of cell signaling networks: a case study of myocyte adrenergic regulation. , 2004, Progress in biophysics and molecular biology.

[31]  T. Eschenhagen β-adrenergic signaling in heart failure—adapt or die , 2008, Nature Medicine.

[32]  Thomas C. Rich,et al.  Roles of GRK and PDE4 Activities in the Regulation of b2 Adrenergic Signaling , 2008 .

[33]  B. Kobilka,et al.  β-Adrenergic Receptor Subtype-Specific Signaling in Cardiac Myocytes from β1 and β2 Adrenoceptor Knockout Mice , 2001 .

[34]  Andrew D McCulloch,et al.  Modeling beta-adrenergic control of cardiac myocyte contractility in silico. , 2003, The Journal of biological chemistry.

[35]  Mats Jirstrand,et al.  Systems biology Systems Biology Toolbox for MATLAB : a computational platform for research in systems biology , 2006 .

[36]  T. Eschenhagen,et al.  β-Adrenergic stimulation and myocardial function in the failing heart , 2009, Heart Failure Reviews.

[37]  C. Sucharov β-adrenergic pathways in human heart failure , 2007 .

[38]  Gunnar Cedersund,et al.  Conclusions via unique predictions obtained despite unidentifiability – new definitions and a general method , 2012, The FEBS journal.

[39]  M. Fung,et al.  Impaired Gsα and adenylyl cyclase cause β-adrenoceptor desensitization in chronically hypoxic rat hearts , 2000 .

[40]  Y. Xiang,et al.  Agonist Dose-dependent Phosphorylation by Protein Kinase A and G Protein-coupled Receptor Kinase Regulates β2 Adrenoceptor Coupling to Gi Proteins in Cardiomyocytes* , 2009, The Journal of Biological Chemistry.

[41]  Harald Martens,et al.  Global structure of sloppiness in a nonlinear model , 2014 .

[42]  Necmettin Yildirim,et al.  β2-Adrenergic Receptor Signaling and Desensitization Elucidated by Quantitative Modeling of Real Time cAMP Dynamics* , 2008, Journal of Biological Chemistry.

[43]  M. Zheng,et al.  The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly. , 2005, Circulation research.

[44]  Jason H. Yang,et al.  Phospholemman is a negative feed-forward regulator of Ca2+ in β-adrenergic signaling, accelerating β-adrenergic inotropy. , 2012, Journal of molecular and cellular cardiology.

[45]  J. Corbin,et al.  Involvement of cAMP-dependent protein kinase in the regulation of heart contractile force. , 1977, The American journal of physiology.

[46]  M. Zheng,et al.  The Enigma of β2-Adrenergic Receptor Gi Signaling in the Heart: The Good, the Bad, and the Ugly , 2005 .